Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chengxin Li
Efficacy and Safety of Dupilumab for the Treatment of Moderate-To-Severe Atopic Dermatitis in Adults
Oncotarget
Oncology
Related publications
605 Efficacy and Safety of Dupilumab in Adolescent Patients With Moderate-To-Severe Atopic Dermatitis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Dupilumab Versus Cyclosporine for Treatment of Moderate-To-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index
Acta Dermato-Venereologica
Dermatology
Medicine
Dupilumab Efficacy and Safety in Moderate-To-Severe Uncontrolled AsthmaEfficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Pediatrics
Child Health
Pediatrics
Perinatology
615 Dupilumab Elicits Rapid and Sustained Improvements in Itch in Adults With Moderate-To-Severe Atopic Dermatitis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Dupilumab for the Treatment of Atopic Dermatitis
Prescriber
Pharmacology
After the Approval of Dupilumab for Moderate-To-Severe Atopic Dermatitis: What Is Next on the Research Agenda?
British Journal of Dermatology
Dermatology
Medicine
A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients With Moderate to Severe Atopic Dermatitis
SKIN The Journal of Cutaneous Medicine
Dupilumab Treatment Improves Quality of Life in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results From a Randomized, Placebo-Controlled Clinical Trial
British Journal of Dermatology
Dermatology
Medicine
Long-Term Safety of Crisaborole Ointment 2% in Children and Adults With Mild-To-Moderate Atopic Dermatitis
Pediatrics
Child Health
Pediatrics
Perinatology
